Biomarkers for Outcomes In Late-life Depression (BOLD)

NCT01082237 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Escitalopram

Sponsor

University of California, Los Angeles

Collaborators

[object Object]